HALO:BMV
Halozyme Therapeutics, Inc.
၂,၂၂၅.၀၀ MX$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၅, GMT-၆ ၁၀:၅၆:၃၀ · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Mkt. cap
ဋေ ၁.၃၈ ထ
Avg. vol.
၄၄၂.၀၀
Volume
၀.၀၀
52-wk high
၂,၂၂၅.၀၀ MX$
52-wk low
၁,၁၂၆.၀၀ MX$
No. of employees
၄၂၃
Mkt. cap
ဋေ ၁.၃၈ ထ
Avg. vol.
၄၄၂.၀၀
Volume
၀.၀၀
52-wk high
၂,၂၂၅.၀၀ MX$
52-wk low
၁,၁၂၆.၀၀ MX$
No. of employees
၄၂၃
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၇ နာရီ
H.C. Wainwright reiterates Halozyme stock rating on Takeda trial data
Timothy Sykes
·
ပြီးခဲ့သည့် ၁ ရက်
HALO Stock Climbs As Dutch Court Injunction Lifts Bullish Bets
StocksToTrade
·
ပြီးခဲ့သည့် ၁ ရက်
HALO Stock Climbs As Patent Win And Deals Lift Outlook
Simply Wall Street
·
ပြီးခဲ့သည့် ၂ ရက်
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees၄၂၃
Founded၁၉၉၈
Headquartersဆန်ဒီရေဂို, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitehalozyme.com